NEW YORK (GenomeWeb News) — The Malaysian Genomics Resource Center will use 454 Life Sciences’ GS FLX sequencer in genomics and bioinformatics projects studying tropical diseases and organisms, 454 said today.
454 said it will work with the MGRC on a number of "high-profile" projects with the Malaysian academic community.
The company said these projects include sequencing microbes with biotechnological and medical applications, as well as large-scale characterization of diseases that are prevalent in Malaysia and the surrounding region.
"Malaysia is investing significant resources in establishing itself as a regional hub for biotechnology research and industrialization," 454 President and CEO Christopher McLeod said in a statement.
By working with the MGRC, 454 aims to realize the “full potential of genomics in Malaysia,” McLeod said.
The MGRC is supported by the Malaysian Biotechnology Corporation, which operates under the Malaysian Ministry of Science, Technology, and Innovation.
It was not immediately clear whether 454 will install a GS FLX at the MGRC, or perform sequencing services at its own facility.